ADAPTIMMUNE THERAPEUTICS PLC Deferred Revenue
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Deferred Revenue of $38.73 million as of 2017-12-31, per its 10-K filed 2019-02-27.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueCurrent · last filed 2019-02-27
- 2017-12-31: Deferred Revenue, Current $38.73M.
- 2017-09-30: Deferred Revenue, Current $42.59M.
- 2017-06-30: Deferred Revenue, Current $12.30M.
- 2017-03-31: Deferred Revenue, Current $11.63M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $38.73M 10-K · filed 2019-02-27 |
| 2017-09-30 | $42.59M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $12.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $11.63M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $11.39M 10-K · filed 2018-03-15 |
| 2016-09-30 | $9.51M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $9.94M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $12.08M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $12.49M 10-K · filed 2017-03-13 |
| 2015-06-30 | $20.91M 10-K · filed 2017-03-13 |
| 2014-06-30 | $41.79M 8-K · filed 2016-07-08 |